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Abstract
This study examined self-efficacy for managing pain, symptoms, and function in patients with lung
cancer and their caregivers, and associations between self-efficacy and patient and caregiver
adjustment. 152 patients with early stage lung cancer completed measures of self-efficacy, pain,
fatigue, quality of life, depression, and anxiety. Their caregivers completed a measure assessing their
self-efficacy for helping the patient manage symptoms and measures of psychological distress and
caregiver strain. Analyses indicated that, overall, patients and caregivers were relatively low in self-
efficacy for managing pain, symptoms, and function, and that there were significant associations
between self-efficacy and adjustment. Patients low in self-efficacy reported significantly higher
levels of pain, fatigue, lung cancer symptoms, depression, and anxiety, and significantly worse
physical and functional well being, as did patients whose caregivers were low in self-efficacy. When
patients and caregivers both had low self-efficacy, patients reported higher levels of anxiety and
poorer quality of life than when both were high in self-efficacy. There were also significant
associations between patient and caregiver self-efficacy and caregiver adjustment, with lower levels
of self-efficacy associated with higher levels of caregiver strain and psychological distress. These
preliminary findings raise the possibility that patient and caregiver self-efficacy for managing pain,
symptoms, and function may be important factors affecting adjustment, and that interventions
targeted at increasing self-efficacy may be useful in this population.
Self-efficacy, or the confidence in one’s ability to perform a specific behavior or task (Bandura,
1997), is one factor that has been examined in relation to patient’s adjustment to cancer. Self-
efficacy for managing pain, symptoms, and function in particular may be critical to a patient’s
ability to manage the physical and psychological challenges of cancer. For several reasons,
lung cancer provides a particularly good model in which to study self-efficacy for pain and
symptom control. First, lung cancer is common, being the second leading site of cancer
occurrence among both men and women with over 174,000 new cases projected for 2006
(American Cancer Society, 2006). Second, lung cancer poses significant challenges for patients
and their caregivers including aggressive medical treatments and an uncertain prognosis. In
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addition to pain, patients often must cope with fatigue, shortness of breath, and other troubling
symptoms (Degner & Sloan, 1995). Finally, clinical observations suggest that lung cancer
patients vary in their confidence that they can manage their symptoms and that those who are
more confident show better adjustment to their disease.
Pain and other symptoms of lung cancer also occur in a social context, affecting both patients
and their caregivers. Family and other informal caregivers increasingly play a central role in
the care of lung cancer patients, providing practical and emotional support, and helping them
monitor symptoms, comply with medical treatments, deal with side effects, and communicate
with health care professionals (Ferrell et al., 1991; Blanchard et al., 1997). Not surprisingly,
caregivers often report high levels of distress, particularly when the patient is experiencing
pain (Miakowski et al., 1997). Like patients, caregivers are likely to vary in their ability to cope
with the challenges they face (Blanchard et al., 1997). Variations in caregiver self-efficacy can
have important implications, not only for the caregiver’s adjustment but also for the patient’s.
One benefit of studying both lung cancer patients and their caregivers is that one can examine
the effects of self-efficacy of patient-caregiver dyads. In some dyads, both patients and
caregivers may report high self-efficacy, whereas in other dyads only one member or neither
member of the dyad may report high self-efficacy. While there is a growing literature regarding
couples’ coping with cancer (e.g. Hagedoorn et al., 2000; Manne & Glassman, 2000; Porter et
al., 2005), very little research has been focused on dyad self-efficacy. An analysis of dyadic
self-efficacy is important because it can shed light on one specific way in which relationships
may impact both patients’ and caregivers’ adjustment to lung cancer.
The current study examined the following hypotheses: (1) that lung cancer patients with high
levels of self-efficacy for managing pain, symptoms, and function would report lower levels
of symptoms, better quality of life, and less psychological distress; (2) that caregivers high in
self-efficacy for helping the patient manage pain, symptoms, and function would report lower
levels of caregiver strain and mood disturbance; and (3) that in dyads where the patient and
caregiver are both high in self-efficacy both would report better adjustment.
Method
Participants
The current study reports on baseline data of 152 patients with early stage lung cancer and their
caregivers who were enrolled in a larger program of research evaluating the efficacy of a
partner-assisted coping skills training intervention. Participants were recruited between
December, 2002 and March, 2005. The entry criteria for patients included having (a) a
diagnosis of early stage lung cancer (non-small cell lung cancer, Stages I-IIIa and IIIb without
pleural effusion, or limited stage small cell lung cancer), (b) no other cancers in the past 5
years, (c) ability to read and speak English, (d) access to a telephone and willing to participate
in a psycheducational intervention, and (e) a caregiver who was also willing to participate. As
is common in the cancer literature, “caregiver” was broadly defined in this study as any friend
or family member who provided practical and/or emotional support to the patient. To identify
the patient’s primary caregiver, the patient was asked to list the people they relied on for support
with things like getting to the doctor and taking medication. They were then asked to review
this list and identify the main person they relied on for support. This person was identified as
the primary caregiver and was invited to participate in the study.
643 patients were screened for inclusion. Of these, 143 were deemed ineligible and 500 were
approached about participation. Of those approached, 316 declined and 184 consented. The
most common reasons for declining included lack of interest (42%), “too much trouble” (6%),
and lack of time (6%). Of the 184 who consented, 32 dropped out prior to completing baseline
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questionnaires primarily because of death/declining health (47%), or loss of time or interest
(41%). This left a sample of 152 dyads (30% of eligible patients) who were included in the
current analyses.
Procedures
Participants were recruited from the Duke University Thoracic Oncology Program as well as
several community oncology clinics in the Durham, NC area. Patients completed a telephone
survey assessing self-efficacy, pain, fatigue, quality of life, and psychological distress.
Caregivers completed a telephone survey assessing their self-efficacy for helping the patient
manage symptoms, and their levels of caregiver strain and mood disturbance. Medical
information for the patient, including cancer stage, treatments, and date of diagnosis, were
extracted from the patient’s medical record. All procedures were approved by the Duke
University Medical Center Institutional Review Board and the Duke Comprehensive Cancer
Center Protocol Review Committee.
Measures
Self-efficacy—Self-efficacy for managing pain, symptoms, and function was assessed with
a modified version of a standard self-efficacy scale (Lorig et al., 1989). The original scale was
modified by removing 9 items relevant to patients with arthritis but not cancer (e.g. “How
certain are you that you can button and unbutton 3 medium-size buttons in a row in 12
seconds?”) and adding 7 items regarding management of pain (from the Chronic Pain Self-
Efficacy scale; Anderson et al. 1995) and other common cancer symptoms such as nausea and
shortness of breath. Patients rated 16 items regarding their perceived ability to manage a variety
of symptoms on a scale of 10 (not at all certain) to 100 (completely certain). The caregiver
version of the instrument is identical to that used with patients except that caregivers are asked
to rate how confident they are that they can help the patient manage symptoms (e.g. “How
certain are you that you can help the patient decrease his/her pain quite a bit?”, “How certain
are you that you can do something to help the patient feel better if he/she is feeling blue?”).
The scale contains three subscales: self-efficacy for managing pain, self-efficacy for managing
other symptoms (e.g. fatigue, nausea, depression), and self-efficacy for function. Because the
three subscales were highly correlated with each other (r’s=.71-.86 for patients; .80-.86 for
caregivers) the total score was utilized for this report. The possible range for the total score is
0 to 100 with higher scores indicating greater self-efficacy. Cronbach alphas for the total scale
score were .95 for patients and .96 for caregivers. Prior studies using this instrument to assess
self-efficacy in lung cancer patients (Porter et al., 2002), prostate cancer patients and their
caregivers (Campbell et al., 2004), and caregivers of cancer patients at the end of life (Keefe
et al., 2003) have demonstrated evidence of internal consistency and construct validity.
Pain—Pain was assessed using two items from the Brief Pain Inventory (BPI; Cleeland &
Ryan, 1994) in which participants rate their usual pain in the past week and their worst pain in
the past week on a scale from 1 (“no pain”) to 10 (“pain as bad as you can imagine”). The worst
and usual BPI pain intensity ratings have demonstrated good test-retest reliability in a sample
of cancer inpatients who completed the second pain ratings 1-7 days later (worst, r=.93; usual,
r=.78) (Daut et al., 1983). The validity of the BPI has also been supported by studies that have
shown a significant relationship between higher pain ratings and increased analgesic and
narcotic use (Daut et al., 1983). Because ratings of usual and worst pain were highly correlated
(r=.89) in the present study, they were combined into a single summary score with a possible
range of 1 to 10 with higher scores indicating more severe pain.
Fatigue was measured using the Brief Fatigue Inventory (BFI; Mendoza et al., 1999). The BFI
has a total of 9 items that measure (a) levels of current fatigue, usual fatigue over the past 24
hours, and worst fatigue over the past 24 hours on a scale from 1 (“no fatigue”) to 10 (“fatigue
Porter et al. Page 3













as bad as you can imagine”); and (b) how fatigue has interfered in the past 24 hours with general
activity, mood, walking ability, normal work (including both work inside and outside the home
and daily chores), relations with other people, and enjoyment of life on a scale of 1 (“does not
interfere”) to 10 (“completely interferes”). Factor analysis has shown that 75% of the variance
on the BFI can be explained by a single factor suggesting that the BFI measures a single
construct (Mendoza et al., 1999). In a study using the BFI to assess fatigue in 305 cancer patients
and 290 healthy control subjects, the patients reported significantly higher levels of fatigue
than the controls, evidence for the sensitivity of the BFI with cancer patients. In addition, the
BFI demonstrated evidence of internal consistency and was correlated with performance status
and with physiological markers of anemia and nutritional status, indicating evidence of
construct validity (Mendoza et al., 1999). Scores on the BFI can range from 1 to 10 with higher
scores indicating more symptoms of fatigue. Cronbach alpha in the current study was .95.
Quality of life was measured using the Functional Assessment of Cancer Therapy - Lung
Cancer (FACT-L; Cella et al., 1995). The FACT-L consists of four general and one lung cancer
symptom-specific subscale. The present study utilized two general subscales (physical well
being and functional well being) along with the lung cancer specific subscale which includes
items assessing shortness of breath, coughing, weight loss, and loss of appetite. These subscales
were chosen as they assess constructs that are conceptually distinct from those assessed by the
other measures used in this study (with the exception of one item of the physical well being
subscale assessing pain). In each subscale, items are rated on a 5-point scale (0=not at all;
4=very much). The possible range on each subscale is 0 to 28 with higher scores indicating
better functioning. The FACT is widely used in cancer studies and both the general measure
and the lung cancer specific measure have been shown to possess adequate psychometric
properties including internal consistency, convergent validity, and sensitivity to change in
performance status ratings (an indicator of patient functional status; Cella et al., 1993, 1995).
Cronbach’s alphas in the present study were .83 (physical well being), .84 (functional well
being), and .73 (lung cancer symptoms).
Depressive symptoms—Depressive symptoms were assessed using the Beck Depression
Inventory (BDI). The BDI is a 21-item self-report inventory assessing current degree of
depression through items pertaining to affective, cognitive, motivational, and physiologic areas
of depressive symptomatology. Total scores can range from 0 to 63, with higher scores
indicating higher levels of depressive symptoms reported (Beck et al., 1961). The BDI has high
internal consistency in clinical and nonclinical populations, and good discriminant, construct,
and concurrent validity (Beck & Beamesderfer, 1974). Cronbach alpha in the current study
was .86.
Anxiety—Anxiety was measured using the trait anxiety version of the State Trait Anxiety
Inventory (STAI; Spielberger, 1983). The STAI was developed as a tool for investigating
anxiety in normal (non-psychiatric) adults, but has been used in assessing anxiety in
neuropsychiatric, medical, and surgical patients. The scale has demonstrated good
psychometric properties (Spielberger, 1983). Cronbach alpha in the current study was .92.
Scores on the trait anxiety scale can range from 20 to 80 with higher scores indicating more
symptoms of anxiety.
Caregiver mood—Caregiver mood was assessed using a brief version of the Profile of Mood
States-B (POMS-B; Lorr & McNair, 1982). Eighteen adjectives -- three each assessing negative
mood states of depression, anxiety, and hostility and three each their positive mood
counterparts of elation, composure, and agreeableness -- were used to rate average mood on
scales from 0=very much unlike this to 3=very much like this. These items were selected from
the larger number appearing on the POMS-B because of their high item-total correlations for
their respective subscales (Affleck et al., 1988). Scores for the total mood disturbance scale of
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the POMS-B can range from -24 to 177 with higher scores indicating greater mood disturbance.
Cronbach’s alpha for the total mood disturbance score was .89.
Caregiver strain—Caregiver strain was assessed with the Caregiver Strain Index (Robinson,
1983), a 13-item scale that assesses a variety of stressors commonly experienced by caregivers.
Sample items include “My sleep has been disturbed because ___ is out of bed, restless, or sick
at night”, and “It is inconvenient (e.g. because helping takes so much time, to prepare meals,
or because appointments take so long”). For each item, the respondent indicates in a yes/no
fashion whether that item applies to him/her, thus yielding a total score ranging from 0 to 13
with higher scores indicative of more burden associated with caregiving. Prior studies have
reported internal consistency scores ranging from .79 (Miaskowski et al., 1997) to .86
(Robinson, 1983). In addition, construct validity of the scale has been determined in three areas:
patient characteristics, caregivers’ subjective perceptions of the caregiving relationship, and
physical and emotional status of the caregiver (Robinson, 1983). In the current study,
Cronbach’s alpha was .84.
Statistical analyses
First, means and standard deviations on the self-efficacy scale were calculated in order to
describe the level of self-efficacy for symptom management reported by lung cancer patients
and their caregivers, and correlation analyses were conducted to determine the degree of
association between patient and caregiver self-efficacy. Associations between self-efficacy and
medical and demographic variables for both patients and caregivers were also examined.
Second, general linear regression analyses were used to examine associations between patient
and caregiver self-efficacy and measures of patient and caregiver adjustment. Demographic
variables (age, gender, and education) and medical status variables (patient’s cancer stage, time
since diagnosis, and current or prior treatment with chemotherapy and radiation) were entered
first as covariates, followed by either patient or caregiver self-efficacy. A separate regression
analysis was conducted for each of the measures of patient and caregiver adjustment. Analyses
of patient adjustment included patient demographics as covariates, while analyses of caregiver
adjustment included caregiver demographics. Third, to examine associations between the level
of self-efficacy of both members of the dyad (the patient and the caregiver) on outcomes,
patients and caregivers were classified as high or low in self-efficacy based on a median split
of their self-efficacy scores and dyads were placed into one of four categories: (1) Both patient
and caregiver are high in self-efficacy; (2) the patient is high in self-efficacy and the caregiver
is low; (3) the patient is low in self-efficacy and the caregiver is high; (4) both patient and
caregiver are low in self-efficacy. Analyses of variance were then used to predict patient and
caregiver adjustment from the dyad self-efficacy category.
Results
Participant Characteristics
Participant characteristics are presented in Table 1. Slightly more than half of the patients
(52.6%) were men, and the majority of caregivers (67%) were women. Both patients and
caregivers were predominantly Caucasian and well-educated. 76% of the caregivers were
spouses of the patient, 14% were sons or daughters, and 8% were sisters, brothers, and friends.
In most cases (73%), the patients and caregivers lived in the same household.
Descriptive analyses
Mean scores on self-efficacy to manage symptoms were 64.4 (SD=21.1, range=14.7-100.0)
for patients and 61.6 (SD=20.9, range=10.0-100.0) for caregivers. These scores are somewhat
lower than those reported in a study of prostate cancer patients (range=71.1-82.9; Campbell et
al., 2004) but slightly higher than those we found in a previous study of lung cancer patients
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(range=56.1-59.3; Porter et al., 2002). The correlation between patient and caregiver self-
efficacy scores was r=.38 (p<.0001).
Regarding pain, 54% of the patients reported they experienced no pain in the past week (BPI
summary score=1), 25% reported mild pain (BPI summary score between 1.5 and 4.5), and
21% reported high levels of pain (BPI summary score of 5 and above).
Analyses were performed to determine whether patients’ self-efficacy scores were related to
any demographic or medical variables using t-tests [for gender, marital status, race (white
versus other), surgery, chemotherapy, and radiation], correlations (for age, education, and time
since diagnosis), and analyses of variance (for type of relationship with the caregiver and cancer
stage). Patient self-efficacy was significantly associated with age (r=.24, p<.01), cancer stage
[F(2,147)=6.79, p<.01], and prior/current treatment with chemotherapy [t (150)=2.50, p<.01]
and radiation [t (150)=3.26, p<.001]. Older patients, patients with Stage 1 and 2 versus Stage
3 disease, and patients who had never received chemotherapy and radiation reported higher
levels of self-efficacy.
Similar analyses were conducted to examine whether caregivers’ self-efficacy scores were
related to demographic or medical variables. Caregiver self-efficacy was significantly
associated with caregiver age (r=.19, p<.05), and with the patient’s prior/current treatment with
chemotherapy [t (150)=2.09, p<.05] and radiation [t (150)=2.11, p<.05] therapy. Older
caregivers and caregivers of patients who had never received chemotherapy and radiation
reported higher levels of self-efficacy.
In order to examine associations between self-efficacy and measures of patient and caregiver
adjustment independent of demographic and medical variables, the following analyses
controlled for age, gender, education, cancer stage, time since diagnosis, and prior/current
treatment with chemotherapy and radiation.
Patient self-efficacy
General linear regression analyses were used to examine associations between patient self-
efficacy and measures of patient and caregiver adjustment. Demographic variables (age,
gender, and education) and medical status variables (patient’s cancer stage, time since
diagnosis, and prior/current treatment with chemotherapy and radiation) were entered first as
covariates, followed by patient self-efficacy. Table 2 summarizes the results of these analyses.
Patient self-efficacy explained significant proportions of the variance in all of the patient and
caregiver measures of adjustment that were examined. Patients with high levels of self-efficacy
reported much lower levels of pain, fatigue, lung cancer symptoms, anxiety, and depression,
and much higher levels of physical well being and functional well being. In addition, when
patients reported high self-efficacy their caregivers reported lower levels of caregiver strain
and mood disturbance.
Caregiver self-efficacy
General linear regression analyses were used to examine associations between caregiver self-
efficacy and measures of patient and caregiver adjustment. Caregiver demographics (age,
gender, and education) and patient medical status variables (patient’s cancer stage, time since
diagnosis, and prior/current treatment with chemotherapy and radiation) were entered first as
covariates, followed by caregiver self-efficacy. Table 3 summarizes the results of these
analyses. Caregiver self-efficacy explained significant proportions of the variance in the
caregiver’s level of mood disturbance, and in patient levels of pain, fatigue, physical and
functional well being, lung cancer specific symptoms, depressive symptoms, and anxiety.
Caregivers who were high in their self-efficacy for helping the patient manage symptoms
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reported lower levels of mood disturbance, and patients whose caregivers were high in self-
efficacy reported much lower levels of pain, fatigue, anxiety, and depression and much higher
levels of quality of life.
In order to determine whether the caregiver’s level of self-efficacy was associated with patient
outcomes independent of the patient’s level of self-efficacy, a second set of regression analyses
was conducted predicting patient adjustment from caregiver self-efficacy with demographic
and medical variables and patient self-efficacy entered first as covariates. Caregiver self-
efficacy continued to show significant associations with patient physical well being [F(1,149)
=4.81, p=.03], functional well being [F(1,149)=7.03, p=.009], and depressive symptoms [F
(1,149)=7.14, p=.008] after controlling for the patient’s level of self-efficacy. The associations
between caregiver self-efficacy and the patient’s lung cancer symptoms and anxiety
approached significance (p’s<.10) while the associations between caregiver self-efficacy and
patient pain and fatigue were no longer significant (p’s>.34).
Dyad Efficacy
We were interested in examining associations between the level of self-efficacy of both
members of the dyad (the patient and the caregiver) and measures of adjustment. To do this,
patients and caregivers were first categorized as high or low in self-efficacy based on a median
split of their self-efficacy scores (which were performed separately for patients and caregivers).
Next, dyads were placed into one of four categories: (1) Both patient and caregiver are high in
self-efficacy (“both high”; n=46, 30.1%); (2) The patient is high in self-efficacy and the
caregiver is low (“patient high-caregiver low”; n=28, 18.3%); (3) The patient is low in self-
efficacy and the caregiver is high (“patient low-caregiver high”; n=30, 19.6%); (4) Both patient
and caregiver are low in self-efficacy (“both low”; n=49, 32.0%).
Bartlett’s test of homogeneity of variances indicated that there were unequal variances across
dyad self-efficacy groups for all of the variables except functional well being and caregiver
strain, violating an assumption of analysis of variance. Thus, weighted least squares analyses
were used to compare the dyad self-efficacy groups on patient pain, fatigue, physical well
being, lung cancer symptoms, depression, anxiety, and caregiver mood, while analyses of
covariance were used to compare the dyad self-efficacy groups on patient functional well being
and caregiver strain. Patient and caregiver age and education, cancer stage, and prior/current
chemotherapy and radiation were entered first as covariates. Results indicated that the dyad
self-efficacy groups differed significantly on the following patient measures: pain [F(10,150)
=9.12, p<.0001], fatigue [F(10,106)=15.52, p<.0001], physical well being [F(10,149)=13.12,
p<.0001], functional well being [F(10,149)=17.33, p<.0001], lung cancer symptoms, [F
(10,149)=13.50, p<.0001], depression [F(10,149)=22.41, p<.0001], and anxiety [F(10,149)
=28.44, p<.0001]. The differences between dyad self-efficacy groups in caregiver strain and
caregiver mood approached significance (p’s<.10).
For those outcome variables in which the overall analysis was significant, post-hoc tests were
conducted to determine significant differences between the four dyad self-efficacy categories.
To balance the concerns of avoiding Type 1 error while attempting to avoid dismissing
potentially important relationships, alpha was set at .01 for the post-hoc analyses. For pain,
fatigue, and depression, patients in “patient high-caregiver high” and “patient high-caregiver
low” dyads reported significantly lower levels of symptoms than patients in “patient low-
caregiver high” and “patient low-caregiver low” dyads (p’s<.01), suggesting a main effect for
patient self-efficacy similar to that found with the regression analyses. For anxiety, patients in
“patient high-caregiver high” dyads reported significantly lower levels than patients in the
other three categories, including patients in “patient high-caregiver low” dyads. In addition,
patients in “patient high-caregiver low” dyads reported lower levels of anxiety than patients
in “patient low-caregiver high” and “patient low-caregiver low” dyads (see Figure 1). For the
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QOL scales (physical well being, functional well being, and lung cancer symptoms), patients
in “patient high-caregiver high” dyads reported significantly higher levels of QOL than patients
in the three other categories. In addition, patients in “patient high-caregiver low” dyads reported
higher QOL in the functional and lung cancer symptom domains than patients in “patient low-
caregiver low” dyads (see Figures 2-4).
Discussion
Findings from this study build on an expanding body of evidence indicating the importance of
self-efficacy in the adjustment of cancer patients. This study adds uniquely to this literature by
(a) using a measure of self-efficacy focused on one particular area of concern for cancer patients
and their caregivers, namely management of pain, symptoms, and function; (b) studying lung
cancer patients, a population that has been understudied despite its prevalence and the high
levels of symptoms and distress associated with the disease; and (c) examining the role of
caregiver self-efficacy in patient and caregiver adjustment.
To our knowledge, this is the first study to directly examine how self-efficacy for managing
pain, symptoms, and function relates to pain and other important outcomes in lung cancer
patients. The results showed that patients who rated their self-efficacy as high experienced
lower levels of pain, fatigue, and psychological distress and higher quality of life. Importantly,
these findings were obtained even after controlling for demographic and medical variables that
could influence pain and other outcomes. It is important to note that the cross-sectional nature
of the data preclude any conclusions regarding the direction of causality. It is possible, for
instance, that lower levels of symptoms and distress resulted in higher perceived self-efficacy,
or that other unmeasured factors led to both higher self-efficacy and lower levels of symptoms
and distress. However, clinical observations suggest that feelings of helplessness and loss of
control are a frequent problem for patients coping with cancer (Akechi et al., 1998; Uchitomi
et al., 2003). The findings of this study suggest that clinicians interested in understanding how
lung cancer patients adapt to their illness may benefit by attending to patients’ perceptions of
self-efficacy. For example, clinicians could listen for expressions of doubt regarding the ability
to manage symptoms and provide those patients with education and resources for self-
management strategies.
Lung cancer not only poses challenges to patients but also to their caregivers. One of the most
interesting findings of this study was that caregivers’ ratings of their own self-efficacy for
helping the patient manage symptoms were significantly related to patients’ ratings of
symptoms and distress. Even after controlling for patients’ self-efficacy ratings, caregivers’
ratings of self-efficacy were meaningfully related to important indices of patient adjustment
such as functional well being, physical well being, and depressive symptoms. Patients with
caregivers high in self-efficacy scored approximately 0.70 standard deviations higher on
functional and physical well being and 0.60 standard deviations lower on depressive symptoms
than patients with caregivers low in self-efficacy, differences that may be clinically significant.
In addition, caregivers’ self-efficacy was meaningfully related to their own mood and level of
caregiver strain. As noted above, the direction of causality of these associations cannot be
determined from this study. However, given the negative impact that a disease such as lung
cancer can have on caregivers, understanding factors such as self-efficacy that may be
associated with improved mood and reduced caregiver strain is particularly important. Overall,
these findings suggest that caregiver self-efficacy ratings may provide unique information that
is useful in understanding patient and caregiver adjustment to lung cancer.
The findings regarding caregiver self-efficacy in lung cancer patients add to a growing body
of literature indicating the important role that spouses and other informal caregivers play in
the adjustment of cancer patients (e.g. Hagedoorn et al, 2000; Manne et al, 2000). While
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preliminary, these findings also raise that possibility that one specific way in which caregivers
can be supportive is by demonstrating confidence in their ability to help the patient manage
their symptoms. Having a caregiver who is low in self-efficacy may compound the patient’s
feelings of helplessness, while having a caregiver who is high in self-efficacy may help bolster
the patient’s resilience. Overall, these findings suggest that the patient’s social environment is
important both in understanding patients’ adjustment and in developing interventions to help
patients manage symptoms and adapt to the challenges associated with their disease (Porter et
al., 2005).
From a clinical perspective, the overall pattern of findings raises the possibility that
interventions targeted at improving self-efficacy may help alleviate patient and caregiver
suffering. There have been several recent intervention studies targeting patient self-efficacy
that have found beneficial effects (Lev et al., 2001; Stiegelis et al., 2004). However, the
interventions tested in these studies were primarily educational, e.g. providing patients with
information about cancer symptoms and possible coping strategies. Findings from the current
study suggest several ways to potentially enhance such interventions. First, techniques based
on self-efficacy theory (e.g. therapist modeling of coping skills, role playing with therapist
feedback, and applying learned skills to challenging situations; Bandura, 1997) could be more
fully integrated into such interventions. This could lead to stronger and more enduring
treatment effects on self-efficacy. Second, given the importance of caregiver self-efficacy for
the patient’s adjustment, including caregivers in interventions may be quite beneficial for both
themselves and the patient. Finally, intervention efforts could target patients who are low in
self-efficacy. These individuals are likely to show the greatest benefits from such interventions,
particularly if their caregivers also have low levels of self-efficacy.
The pattern of findings obtained suggested that self-efficacy was associated with the various
measures of adjustment in similar ways. This is not surprising given that pain, fatigue, quality
of life, and psychological distress tend to be inter-related (and were highly correlated with each
other in this sample with r’s ranging from .46 to .73). While this may reflect shared method
variance, it is also consistent with the observation that symptoms and psychological distress
tend to cluster together in lung cancer patients (e.g. Fox & Lyon, 2006; Wang et al., 2006).
One implication of this phenomenon is the possibility that interventions designed to enhance
self-efficacy may improve patient adjustment across a variety of domains, rather than having
to target specific symptoms with specific interventions.
While it may be possible to target multiple symptoms with an intervention to enhance self-
efficacy, it may be necessary to define self-efficacy as it relates to adjustment to cancer more
precisely than has been done to date. Previous studies in this area have utilized a variety of
self-efficacy measures, many of which assess patients’ confidence in their ability to cope with
a wide range of challenges (e.g. obtaining information, maintaining a positive attitude, seeking
social support; Merluzzi et al., 2001; Wolfe et al., 2005). The use of such global measures
makes it difficult to identify the ways in which self-efficacy might be related to specific
problems in adjustment. From both a research and clinical perspective, it may be helpful to
identify and measure specific domains of self-efficacy. An intervention targeted at self-efficacy
for seeking social support, for instance, would look quite different from one targeting symptom
management, and would likely produce disparate results.
The findings from this study also suggest that further research on the impact of dyad self-
efficacy is warranted. Longitudinal studies involving multiple measures of both patient and
caregiver self-efficacy would be particularly valuable in understanding how patient and
caregiver self-efficacy covary across time, and the influence this has on each person’s
adjustment. Patient and caregiver responses to interventions designed to enhance self-efficacy
could also help determine when and with whom it is most helpful to focus intervention efforts.
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For instance, it may be possible to identify circumstances (e.g. at the end-of-life) or patient
characteristics (e.g. extremely high levels of psychological distress) that make it more effective
to intervene with a caregiver as opposed to a patient. Alternatively, it may be possible to identify
patient-caregiver dyads (e.g. those in which both individuals are low in self-efficacy) who are
most likely to benefit from a joint intervention.
This study has a number of limitations. First, the study design was correlational. Thus, it is not
possible to determine whether low levels of patient/caregiver self-efficacy leads to increases
in patient symptoms and decreases in patient QOL or vice versa. However, there has been at
least one longitudinal study indicating that cancer patients’ self-efficacy at one time point is
associated with subsequent levels of psychological distress (Lev et al., 1999). In addition,
findings from recent intervention studies targeting cancer patients’ self-efficacy suggest that
these interventions can indeed result in reductions in psychological distress (Stiegelis et al.,
2004) and symptom distress (Lev et al., 2001). Second, the generalizability of the findings may
be compromised by the high refusal rate for the study, and the predominance of white, well
educated participants. Additional studies with larger, more representative, and more ethnically
diverse samples are warranted. A third limitation is that the findings were based on self-report
measures of inter-related constructs, raising the possibility that shared method variance may
partially account for the associations. However, as noted above, the pattern of results is
consistent with the observation that symptoms and psychological distress tend to cluster in
lung cancer patients (e.g. Fox & Lyon, 2006; Wang et al., 2006). Future studies should consider
including objective measures of disease severity and clinical ratings of symptoms and distress
in order to increase the validity of their results.
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Box plots displaying patient anxiety by dyad self-efficacy category. Medians are indicated by
the horizontal line within each box, the 25th and 75th percentiles by the upper and lower boxes,
nearest values not beyond 1.5 times the interquartile range with whiskers, and outliers with
dots. The overall weighted least squares analysis was significant (p<.0001). Groups with
differing subscripts differed significantly from each other (p’s<.01).
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Box plots displaying patient physical well being by dyad self-efficacy category. Medians are
indicated by the horizontal line within each box, the 25th and 75th percentiles by the upper
and lower boxes, nearest values not beyond 1.5 times the interquartile range with whiskers,
and outliers with dots. The overall weighted least squares analysis was significant (p’s<.0001).
Groups with differing subscripts differed significantly from each other (p’s<.01).
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Box plots displaying patient functional well being by dyad self-efficacy category. Medians are
indicated by the horizontal line within each box, the 25th and 75th percentiles by the upper
and lower boxes, nearest values not beyond 1.5 times the interquartile range with whiskers,
and outliers with dots. The overall weighted least squares analysis was significant (p’s<.0001).
Groups with differing subscripts differed significantly from each other (p’s<.01).
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Box plots patient lung cancer symptoms by dyad self-efficacy category. Medians are indicated
by the horizontal line within each box, the 25th and 75th percentiles by the upper and lower
boxes, nearest values not beyond 1.5 times the interquartile range with whiskers, and outliers
with dots. The overall weighted least squares analysis was significant (p’s<.0001). Groups with
differing subscripts differed significantly from each other (p’s<.01).
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Table 1
Participant characteristics
Patients (N=152) Caregivers (N=152)
Mean age (SD) 65.1 (9.8) 60.0 (13.2)
Gender (% male) 52.6 33.6
Race
 Caucasian 86.8% 85.7%
 African American 11.2% 10.9%
 Native American 1.3% 0.7%
 Other 0.7% 2.7%
Education
 <12 years 15.1% 7.9%
 High school graduate 30.3% 34.2%
 Some college 27.6% 27.6%
 College graduate 15.8% 12.5%
 Post-graduate 11.2% 17.8%





 Chemotherapy - current 12.7%
 Chemotherapy - in past 33.1%
 Radiation - current 6.0%





   Limited stage N=4 (2.6%)
*
Note: Staging information was not available for one participant.
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Table 2
Summary of regression analyses predicting patient adjustment and caregiver adjustment from patient self-efficacy
Measure F* p* Total Model R2* Change in R
2 with self-
efficacy added
Pain 26.53 <.0001 .31 .13
Fatigue 56.46 <.0001 .48 .33
Physical well being 39.45 <.0001 .40 .18
Functional well being 107.60 <.0001 .53 .37
Lung cancer QOL 67.37 <.0001 .43 .28
Depressive symptoms 74.63 <.0001 .47 .30
Anxiety 69.19 <.0001 .48 .26
Caregiver strain 5.28 .02 .37 .16
Caregiver mood disturbance 10.63 .001 .34 .12
*
Note: For patient outcomes, the total model included patient age, patient gender, patient education, cancer stage, time since diagnosis, and treatment with
chemotherapy and radiation in addition to self-efficacy. For caregiver outcomes, the total model included caregiver age, caregiver gender, caregiver
education, and the patient’s medical variables (cancer stage, time since diagnosis, and treatment with chemotherapy and radiation) in addition to self-
efficacy. F and p values refer to the contribution of patient self-efficacy in the total model.
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Table 3
Summary of regression analyses predicting patient adjustment and caregiver adjustment from caregiver self-efficacy
Measure F* p* Total Model R2* Change in R
2 with self-
efficacy added
Pain 6.81 .01 .22 .04
Fatigue 9.00 .004 .23 .08
Physical well being 15.95 .0001 .31 .09
Functional well being 25.20 <.0001 .29 .13
Lung cancer QOL 15.02 .0002 .23 .08
Depressive symptoms 23.44 <.0001 .30 .13
Anxiety 16.73 <.0001 .30 .08
Caregiver strain 3.72 .06 .37 .16
Caregiver mood disturbance 5.71 .02 .31 .09
*
Note: For patient outcomes, the total model included patient age, patient gender, patient education, cancer stage, time since diagnosis, and treatment with
chemotherapy and radiation in addition to self-efficacy. For caregiver outcomes, the total model included caregiver age, caregiver gender, caregiver
education, and the patient’s medical variables (cancer stage, time since diagnosis, and treatment with chemotherapy and radiation) in addition to self-
efficacy. F and p values refer to the contribution of caregiver self-efficacy in the total model.
Pain. Author manuscript; available in PMC 2009 July 15.
